Ji-Lin Chen Selected Research

BES

3/2009

Two-year clinical outcome after successful implantation of drug-eluting and bare metal stents in diabetic patients: results from a real-world single center registry.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ji-Lin Chen Research Topics

Disease

21	Myocardial Infarction 11/2016 - 02/2003
18	Thrombosis (Thrombus) 11/2016 - 12/2006
16	Cardiovascular Diseases (Cardiovascular Disease) 11/2016 - 12/2006
14	Neoplasms (Cancer) 12/2023 - 08/2018
5	Triple Negative Breast Neoplasms 12/2023 - 01/2017
5	Inflammation (Inflammations) 01/2022 - 01/2005
5	Coronary Artery Disease (Coronary Atherosclerosis) 10/2011 - 06/2007
5	Infarction (Infarctions) 09/2010 - 02/2003
5	Death (Near-Death Experience) 03/2009 - 06/2007
4	Breast Neoplasms (Breast Cancer) 12/2023 - 01/2017
4	Neoplasm Metastasis (Metastasis) 01/2023 - 08/2018
4	Hemorrhage 01/2016 - 08/2009
4	Coronary Disease (Coronary Heart Disease) 09/2013 - 07/2008
4	AIDS-Related Complex (ARC) 04/2011 - 07/2008
4	Necrosis 06/2008 - 03/2005
3	Hypoxia (Hypoxemia) 11/2023 - 12/2022
3	Reperfusion Injury 01/2022 - 04/2007
3	Unstable Angina 10/2010 - 03/2007
2	Carcinogenesis 11/2023 - 04/2020
2	Diabetic Retinopathy (Retinopathy, Diabetic) 11/2023 - 01/2023
2	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2022 - 01/2022
2	Pathologic Constriction (Stenosis) 01/2020 - 07/2008
2	Diabetes Mellitus 03/2009 - 09/2008
2	Myocardial Ischemia (Ischemic Heart Diseases) 02/2008 - 04/2007
2	Atherosclerosis 02/2005 - 01/2005
1	Spinal Cord Injuries (Spinal Cord Injury) 12/2023
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 12/2023
1	Pathologic Complete Response 12/2023
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2022
1	Brain Ischemia (Cerebral Ischemia) 01/2022
1	Ischemia 01/2022
1	Lung Neoplasms (Lung Cancer) 01/2022
1	Adenocarcinoma of Lung 01/2022
1	Colonic Neoplasms (Colon Cancer) 01/2021
1	Colorectal Neoplasms (Colorectal Cancer) 01/2021

Drug/Important Bio-Agent (IBA)

13	omega-Chloroacetophenone (Mace)IBA 10/2012 - 12/2006
5	Clopidogrel (Plavix)FDA Link 11/2016 - 02/2005
4	Proteins (Proteins, Gene)FDA Link 01/2023 - 02/2019
4	Cytochrome P-450 CYP2C19IBA 11/2016 - 07/2011
3	Messenger RNA (mRNA)IBA 12/2023 - 01/2021
3	Estrogen ReceptorsIBA 12/2023 - 01/2017
3	Long Noncoding RNAIBA 11/2023 - 12/2022
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 04/2020 - 03/2007
3	Protein Phosphatase 2 (Protein Phosphatase 2A)IBA 02/2019 - 08/2018
3	Sirolimus (Rapamycin)FDA Link 09/2008 - 06/2007
2	Histones (Histone)IBA 11/2023 - 01/2023
2	RNA (Ribonucleic Acid)IBA 11/2023 - 12/2022
2	Lysine (L-Lysine)FDA Link 11/2023 - 01/2023
2	MicroRNAs (MicroRNA)IBA 01/2022 - 10/2015
2	Neuroprotective AgentsIBA 01/2022 - 01/2022
2	Biomarkers (Surrogate Marker)IBA 10/2021 - 08/2018
2	Kynurenine 3-Monooxygenase (Kynurenine 3 Monooxygenase)IBA 01/2021 - 04/2020
2	KynurenineIBA 01/2021 - 04/2020
2	EnzymesIBA 04/2020 - 04/2020
2	erucylphosphocholineIBA 09/2010 - 04/2007
2	Phosphates (Orthophosphate)IBA 02/2008 - 04/2007
2	BuffersIBA 02/2008 - 04/2007
2	salicylhydroxamic acid (SHAM)IBA 03/2005 - 02/2003
1	IntegrinsIBA 12/2023
1	Glial Fibrillary Acidic ProteinIBA 12/2023
1	Complement System Proteins (Complement)IBA 12/2023
1	AgarIBA 11/2023
1	BerberineIBA 11/2023
1	scutellarinIBA 01/2023
1	Monoclonal AntibodiesIBA 01/2023
1	CalreticulinIBA 01/2023
1	Adenosine Triphosphate (ATP)IBA 01/2023
1	regorafenibIBA 01/2023
1	Histone Acetyltransferases (Histone Acetyltransferase)IBA 01/2023
1	HMGB1 Protein (HMG1)IBA 01/2023
1	MethyltransferasesIBA 12/2022
1	ChromatinIBA 12/2022
1	A-Form DNA (A-DNA)IBA 12/2022
1	Exonucleases (3' 5' Exonuclease)IBA 12/2022
1	Capsules (Microcapsules)IBA 01/2022
1	LipopolysaccharidesIBA 01/2022
1	Phosphoprotein Phosphatases (Phosphatases, Protein)IBA 01/2022
1	Phosphotransferases (Kinase)IBA 01/2022
1	Caspase 3 (Caspase-3)IBA 01/2022
1	Tyrosine (L-Tyrosine)FDA Link 01/2022
1	Agammaglobulinaemia Tyrosine KinaseIBA 01/2022
1	CytokinesIBA 01/2022
1	Cytokine Receptors (Cytokine Receptor)IBA 01/2022
1	ibrutinibIBA 01/2022
1	AntagomirsIBA 01/2022
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 10/2021
1	Glycoproteins (Glycoprotein)IBA 01/2021
1	Tryptophan (L-Tryptophan)FDA Link 01/2021
1	3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA)IBA 04/2020

Therapy/Procedure

20	Stents 11/2016 - 12/2006
6	Drug-Eluting Stents 01/2020 - 07/2008
5	Therapeutics 12/2023 - 01/2009
5	Percutaneous Coronary Intervention 09/2013 - 01/2009
3	Ligation 06/2008 - 03/2005
2	Immunotherapy 01/2023 - 10/2021
2	Length of Stay 01/2016 - 10/2010
1	Neoadjuvant Therapy 12/2023
1	Drug Therapy (Chemotherapy) 12/2023
1	Oral Administration 01/2022
1	Precision Medicine 10/2021